Distinct GluN1 and GluN2 Structural Determinants for Subunit-Selective Positive Allosteric Modulation of N-Methyl-d-aspartate Receptors. 2021

Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
Department of Pharmacology, Emory University, 1510 Clifton Road, Atlanta, Georgia 30322, United States.

N-Methyl-d-aspartate receptors (NMDARs) are ionotropic ligand-gated glutamate receptors that mediate fast excitatory synaptic transmission in the central nervous system (CNS). Several neurological disorders may involve NMDAR hypofunction, which has driven therapeutic interest in positive allosteric modulators (PAMs) of NMDAR function. Here we describe modest changes to the tetrahydroisoquinoline scaffold of GluN2C/GluN2D-selective PAMs that expands activity to include GluN2A- and GluN2B-containing recombinant and synaptic NMDARs. These new analogues are distinct from GluN2C/GluN2D-selective compounds like (+)-(3-chlorophenyl)(6,7-dimethoxy-1-((4-methoxyphenoxy)methyl)-3,4-dihydroisoquinolin-2(1H)-yl)methanone (CIQ) by virtue of their subunit selectivity, molecular determinants of action, and allosteric regulation of agonist potency. The (S)-enantiomers of two analogues (EU1180-55, EU1180-154) showed activity at NMDARs containing all subunits (GluN2A, GluN2B, GluN2C, GluN2D), whereas the (R)-enantiomers were primarily active at GluN2C- and GluN2D-containing NMDARs. Determination of the actions of enantiomers on triheteromeric receptors confirms their unique pharmacology, with greater activity of (S) enantiomers at GluN2A/GluN2D and GluN2B/GluN2D subunit combinations than (R) enantiomers. Evaluation of the (S)-EU1180-55 and EU1180-154 response of chimeric kainate/NMDA receptors revealed structural determinants of action within the pore-forming region and associated linkers. Scanning mutagenesis identified structural determinants within the GluN1 pre-M1 and M1 regions that alter the activity of (S)-EU1180-55 but not (R)-EU1180-55. By contrast, mutations in pre-M1 and M1 regions of GluN2D perturb the actions of only the (R)-EU1180-55 but not the (S) enantiomer. Molecular modeling supports the idea that the (S) and (R) enantiomers interact distinctly with GluN1 and GluN2 pre-M1 regions, suggesting that two distinct sites exist for these NMDAR PAMs, each of which has different functional effects.

UI MeSH Term Description Entries
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D009435 Synaptic Transmission The communication from a NEURON to a target (neuron, muscle, or secretory cell) across a SYNAPSE. In chemical synaptic transmission, the presynaptic neuron releases a NEUROTRANSMITTER that diffuses across the synaptic cleft and binds to specific synaptic receptors, activating them. The activated receptors modulate specific ion channels and/or second-messenger systems in the postsynaptic cell. In electrical synaptic transmission, electrical signals are communicated as an ionic current flow across ELECTRICAL SYNAPSES. Neural Transmission,Neurotransmission,Transmission, Neural,Transmission, Synaptic
D000494 Allosteric Regulation The modification of the reactivity of ENZYMES by the binding of effectors to sites (ALLOSTERIC SITES) on the enzymes other than the substrate BINDING SITES. Regulation, Allosteric,Allosteric Regulations,Regulations, Allosteric
D016194 Receptors, N-Methyl-D-Aspartate A class of ionotropic glutamate receptors characterized by affinity for N-methyl-D-aspartate. NMDA receptors have an allosteric binding site for glycine which must be occupied for the channel to open efficiently and a site within the channel itself to which magnesium ions bind in a voltage-dependent manner. The positive voltage dependence of channel conductance and the high permeability of the conducting channel to calcium ions (as well as to monovalent cations) are important in excitotoxicity and neuronal plasticity. N-Methyl-D-Aspartate Receptor,N-Methyl-D-Aspartate Receptors,NMDA Receptor,NMDA Receptor-Ionophore Complex,NMDA Receptors,Receptors, NMDA,N-Methylaspartate Receptors,Receptors, N-Methylaspartate,N Methyl D Aspartate Receptor,N Methyl D Aspartate Receptors,N Methylaspartate Receptors,NMDA Receptor Ionophore Complex,Receptor, N-Methyl-D-Aspartate,Receptor, NMDA,Receptors, N Methyl D Aspartate,Receptors, N Methylaspartate

Related Publications

Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
January 1990, Advances in pharmacology (San Diego, Calif.),
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
May 2018, Molecular pharmacology,
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
October 2005, Molecular pharmacology,
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
June 2023, The Journal of general physiology,
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
December 2009, Biochemical Society transactions,
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
December 1997, Molecular pharmacology,
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
May 2010, The Journal of biological chemistry,
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
October 2017, Neuropharmacology,
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
June 2016, Journal of biomolecular screening,
Katie L Strong, and Matthew P Epplin, and Kevin K Ogden, and Pieter B Burger, and Thomas M Kaiser, and Timothy J Wilding, and Hiro Kusumoto, and Chad R Camp, and Gil Shaulsky, and Subhrajit Bhattacharya, and Riley E Perszyk, and David S Menaldino, and Miranda J McDaniel, and Jing Zhang, and Phuong Le, and Tue G Banke, and Kasper B Hansen, and James E Huettner, and Dennis C Liotta, and Stephen F Traynelis
October 2015, The European journal of neuroscience,
Copied contents to your clipboard!